Has Rishi Pathak, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,739 in general payments to Rishi Pathak, MD across 71 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rishi Pathak, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rishi Pathak, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rishi Pathak, MD

Physical Medicine & Rehabilitation · Hammond, LANPI 1861836868

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 61.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $808, 4.7 times the $170 reported in 2023.

$1,739in general payments, 2019–2025

Across 71 payments — averaging $24.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
AstraZeneca$240
Medtronic$173
Boehringer Ingelheim$87
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$65
Argenx US, Inc.$29
plus $80 from 4 others

What the payments were for

Food & beverage$1,739100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	59	$1,065
AstraZeneca	2	$240
Medtronic	2	$173
Boehringer Ingelheim	1	$87
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$65
Argenx US, Inc.	1	$29
Ipsen Biopharmaceuticals, Inc	1	$28
Dynasplint Systems Inc.	1	$18
Pfizer	1	$18
Lilly USA, LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AIRSUPRA$240
HawkOne$142
BOTOX$125

How this compares

$1,739 in reported general payments places this provider in the 75th percentile of 117 physical medicine & rehabilitation providers in Louisiana.

See all physical medicine & rehabilitation providers in Louisiana →

Medicare billing

Part B allowed, 2024

$315,951

Medicare patients

301

Services billed

4,012

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ropinirole ErRopinirole Hcl	12	$2,781
Etodolac	13	$755
Gabapentin	38	$640
AmantadineAmantadine Hcl	16	$245
Methocarbamol	15	$243
Baclofen	22	$170
Atorvastatin Calcium	12	$121
ClopidogrelClopidogrel Bisulfate	14	$114
Venlafaxine Hcl ErVenlafaxine Hcl	18	$111
Duloxetine Hcl	18	$102
Escitalopram Oxalate	16	$85
Metoprolol Succinate	12	$69
Topiramate	13	$61
Amlodipine Besylate	16	$56
Pantoprazole Sodium	12	$49

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Hammond

Thien NinhHammond$269
William RogenmoserAlexandria$350K
Andrea ToomerMarrero$170K
Taylor ColonCovington$26K
Erik DavisMetairie$12K
Stephen RynickMarrero$12K
Fred DefranceschMetairie$11K
Eric FinckeNew Orleans$9K
Casey MurphyNew Orleans$8K
Joshua KaufmanNew Orleans$8K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →